Your Catalyst Learning Hub: Advancing Respiratory Treatment Paradigms

Welcome, Catalyst!

Your “Clinical Reflections” quiz results suggest a passion for advancing treatment paradigms. The ADVENT program brings together emerging data and perspectives to support informed clinical decision-making. Explore curated resources to help translate the latest insights into practice.

What You'll Discover in Your Catalyst Learning Hub

Dive into curated resources to fuel your drive for innovation and deep scientific insights. This content will help you translate complex science into actionable clinical strategies.

Ready to push the boundaries? Explore your personalized resources and lead the way in respiratory innovation

Screen depicting a mucus plug in the airways

Pulmonology

4 min

videoanimation

A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

Pulmonology

3 min

Infographic

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

Pulmonology

21 min

Podcast

ADVENT On Air | Disease Modification in Severe Asthma: Framework, Assessment, and Clinical Impact

Type 2 Inflammation

2 min

expert video

Impact of Exacerbations in COPD

Pulmonology

4 min

videoanimation

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

MAT-GLB-2602169 - 1.0 - 05/2026

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Costa RicaChange country/region